MedTrace Logo

Pore Excision, Curettage, and Injection of Cymetra for Pilonidal Disease

NCT00493493 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2007-06-28

No results posted yet for this study

Summary

Chronic pilonidal disease is a common problem with no ideal treatment. This is a prospective study that will evaluate the results of surgical pore excision, curettage, and injection of a regenerative tissue matrix, Cymetra, on patients with chronic pilonidal disease.

Conditions

  • Pilonidal Sinus

Interventions

PROCEDURE

surgery (Pore Excision, Curettage, and Injection of Cymetra)

Sponsors & Collaborators

  • LifeCell

    collaborator INDUSTRY

  • Matino, James, M.D.

    lead INDIV

Principal Investigators

  • James J Matino, MD · Surgical Group,PC

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Completion
2008-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00493493 on ClinicalTrials.gov